BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23794078)

  • 1. Blood concentrations of cefuroxime in cardiopulmonary bypass surgery.
    Bertholee D; ter Horst PG; Hijmering ML; Spanjersberg AJ; Hospes W; Wilffert B
    Int J Clin Pharm; 2013 Oct; 35(5):798-804. PubMed ID: 23794078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting cefuroxime plasma concentrations during coronary artery bypass graft surgery with cardiopulmonary bypass.
    Aalbers M; ter Horst PG; Hospes W; Hijmering ML; Spanjersberg AJ
    Int J Clin Pharm; 2015 Aug; 37(4):592-8. PubMed ID: 25791346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of cardiopulmonary bypass on cefuroxime plasma concentration and pharmacokinetics in patients undergoing coronary surgery.
    Ferreira F; Santos S; Nascimento J; Strabelli T; Carmona M
    Eur J Cardiothorac Surg; 2012 Aug; 42(2):300-5. PubMed ID: 22290920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic availability of prophylactic cefuroxime in patients submitted to coronary artery bypass grafting with cardiopulmonary bypass.
    Nascimento JW; Carmona MJ; Strabelli TM; Auler JO; Santos SR
    J Hosp Infect; 2005 Apr; 59(4):299-303. PubMed ID: 15749317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cefuroxime in infants and neonates undergoing cardiac surgery.
    Gertler R; Gruber M; Wiesner G; Grassin-Delyle S; Urien S; Tassani-Prell P; Martin K
    Br J Clin Pharmacol; 2018 Sep; 84(9):2020-2028. PubMed ID: 29761538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue and plasma concentrations of cephuroxime during cardiac surgery in cardiopulmonary bypass--a microdialysis study.
    Mand'ák J; Pojar M; Maláková J; Lonsk V; Palicka V; Zivný P
    Perfusion; 2007 Mar; 22(2):129-36. PubMed ID: 17708162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue and plasma concentrations of antibiotic during cardiac surgery with cardiopulmonary bypass--microdialysis study.
    Pojar M; Mandak J; Malakova J; Jokesova I
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Jun; 152(1):139-45. PubMed ID: 18795089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is single-dose antibiotic prophylaxis sufficient for coronary artery bypass surgery? An analysis of peri- and postoperative serum cefuroxime and vancomycin levels.
    Vuorisalo S; Pokela R; Syrjälä H
    J Hosp Infect; 1997 Nov; 37(3):237-47. PubMed ID: 9421775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population Pharmacokinetic Model-Based Evaluation of Standard Dosing Regimens for Cefuroxime Used in Coronary Artery Bypass Graft Surgery with Cardiopulmonary Bypass.
    Alqahtani SA; Alsultan AS; Alqattan HM; Eldemerdash A; Albacker TB
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29358296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetic evaluation of cefuroxime in perioperative antibiotic prophylaxis during and after cardiopulmonary bypass.
    Rimmler C; Lanckohr C; Mittrup M; Welp H; Würthwein G; Horn D; Fobker M; Ellger B; Hempel G
    Br J Clin Pharmacol; 2021 Mar; 87(3):1486-1498. PubMed ID: 32959896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiologically based pharmacokinetic evaluation of cefuroxime in perioperative antibiotic prophylaxis.
    Rimmler C; Lanckohr C; Akamp C; Horn D; Fobker M; Wiebe K; Redwan B; Ellger B; Koeck R; Hempel G
    Br J Clin Pharmacol; 2019 Dec; 85(12):2864-2877. PubMed ID: 31487057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative cefuroxime pharmacokinetics in cardiac surgery.
    Nascimento JW; Carmona MJ; Strabelli TM; Auler JO; Santos SR
    Clinics (Sao Paulo); 2007 Jun; 62(3):257-60. PubMed ID: 17589665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neither moxifloxacin nor cefuroxime produces significant attenuation of inflammatory mediator release in patients exposed to cardiopulmonary bypass: a randomized controlled trial.
    Wiesner G; Braun SL; Gruber M; Gertler R; Lange R; Tassani P; Martin K
    J Antimicrob Chemother; 2012 Jan; 67(1):230-3. PubMed ID: 21972268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Importance of Perioperative Prophylaxis with Cefuroxime or Ceftriaxone in the Surgical Site Infections Prevention after Cranial and Spinal Neurosurgical Procedures.
    Dimovska-Gavrilovska A; Chaparoski A; Gavrilovski A; Milenkovikj Z
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2017 Sep; 38(2):85-97. PubMed ID: 28991759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colo-Pro: a pilot randomised controlled trial to compare standard bolus-dosed cefuroxime prophylaxis to bolus-continuous infusion-dosed cefuroxime prophylaxis for the prevention of infections after colorectal surgery.
    Kirby A; Asín-Prieto E; Burns FA; Ewin D; Fatania K; Kailavasan M; Nisar S; Pericleous A; Trocóniz IF; Burke D
    Eur J Clin Microbiol Infect Dis; 2019 Feb; 38(2):357-363. PubMed ID: 30519893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penetration of cefuroxime in subcutaneous tissue during coronary artery bypass grafting surgery.
    Nascimento JW; Carmona MJ; Strabelli TM; Auler JO; Santos SR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Dec; 877(31):3960-4. PubMed ID: 19853540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cardiopulmonary bypass on the disposition of cefazolin in patients undergoing cardiothoracic surgery.
    Asada M; Nagata M; Mizuno T; Uchida T; Kurashima N; Takahashi H; Makita K; Arai H; Echizen H; Yasuhara M
    Pharmacol Res Perspect; 2018 Dec; 6(6):e00440. PubMed ID: 30410768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefuroxime pharmacokinetics in pediatric cardiovascular surgery patients undergoing cardiopulmonary bypass.
    Knoderer CA; Saft SA; Walker SG; Rodefeld MD; Turrentine MW; Brown JW; Healy DP; Sowinski KM
    J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):425-30. PubMed ID: 20864357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefuroxime plasma and tissue concentrations in patients undergoing elective cardiac surgery: Continuous vs bolus application. A pilot study.
    Skhirtladze-Dworschak K; Hutschala D; Reining G; Dittrich P; Bartunek A; Dworschak M; Tschernko EM
    Br J Clin Pharmacol; 2019 Apr; 85(4):818-826. PubMed ID: 30636060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interrupted time series analysis of vancomycin compared to cefuroxime for surgical prophylaxis in patients undergoing cardiac surgery.
    Garey KW; Lai D; Dao-Tran TK; Gentry LO; Hwang LY; Davis BR
    Antimicrob Agents Chemother; 2008 Feb; 52(2):446-51. PubMed ID: 18025116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.